Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks. - Wikidata - awgldk - TriplyDB

Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks.

Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks.

http://www.wikidata.org/entity/Q35127445

about

Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant survey Darunavir : a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infection.Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment.Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.Effect of darunavir on lipid profile in HIV-infected patients.Darunavir: a review of its use in the management of HIV-1 infection.Treating women with HIV: is it different than treating men?

P2860

Q24605774-90E271C7-5E5D-4B4E-852B-EAC6E93160DE Q34638302-35C1D21E-4934-4FAB-BA56-B19DA9A22FE7 Q35093189-DAB82210-88A4-485A-8056-92B65CD98B25 Q36250357-52246357-6E93-4E4E-A5E4-AC92156B6F7C Q38058385-48ADDA8E-502A-4B93-9FF8-A10204DB6F50 Q38171346-644E8E11-4A22-4364-8D7E-0A38B68D532F Q46341976-B3E31D4B-9E44-4EC0-B7D0-C48B629E3534

P2860

Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks.

http://www.wikidata.org/entity/Q35127445

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Effects of darunavir/ritonavir ...... n women and men over 48 weeks.

@ast

Effects of darunavir/ritonavir ...... n women and men over 48 weeks.

@en

type

label

Effects of darunavir/ritonavir ...... n women and men over 48 weeks.

@ast

Effects of darunavir/ritonavir ...... n women and men over 48 weeks.

@en

prefLabel

Effects of darunavir/ritonavir ...... n women and men over 48 weeks.

@ast

Effects of darunavir/ritonavir ...... n women and men over 48 weeks.

@en

P1433

Q35127445-DE5E4E5D-AF63-46D6-9C60-F062822DC1E7

P1476

Q35127445-6E5CAC5A-D6DE-4BAE-AC7C-79532831DC39

P2093

Q35127445-63B6EA7B-083B-47E0-BA6F-F56A7C2CFE4A

Q35127445-6B6D27B4-EA1B-4608-BB89-D6DD2B6D40E4

Q35127445-9BE9E3CD-0657-4B06-A74E-8E5782BEFFAD

Q35127445-A0CB7722-D9BE-4E8F-8FFD-9277DC9F9298

Q35127445-B21FE346-CA66-4C6F-AEED-E41FFF3CC712

Q35127445-BBD8AB68-91CF-4D06-913B-79684DA61A18

Q35127445-F6D12D16-B3AF-4FBE-9B63-6D814E900028

P2860

Q35127445-24F1FF6A-E1F0-47B6-905B-96CBE9276DCF

Q35127445-2CEAADC4-87CE-42A4-844E-95B732792FA6

Q35127445-42714E55-1971-4CA3-B23C-D95F60F87955

Q35127445-56BDA51E-1114-4056-9FD6-848A802A3386

Q35127445-61828589-9EBD-4FF8-B3CF-BD3C0D377035

Q35127445-6F0DDD4C-8133-479D-8718-54817648161F

Q35127445-938C6FB2-17EA-4F61-9098-8C8BB2125D20

Q35127445-9E2F194C-CD77-4548-BAC0-6BBDFB1DB654

Q35127445-A628D4BE-2618-4996-A108-0C13DE9B66A3

Q35127445-C6B8C0A1-5BA0-4320-8C22-A6A910560339

P304

Q35127445-ED267BE1-355F-4D22-842C-6D4EBB217FD0

P31

Q35127445-7D53F2E7-0476-49C4-8471-CBF51FF8F396

P356

Q35127445-DB93ECD0-DDAA-4950-AB16-78BD5CD2E45D

P433

Q35127445-DBF2C4A8-EC4A-43F9-AEC4-E83AFD71F252

P478

Q35127445-9015FEB7-8EC5-4224-82E9-52FBCB7BBA7A

P577

Q35127445-AA04688A-E064-48F9-836C-05B1C2D8AF5C

P5875

Q35127445-61C64A79-6BC6-4611-9A0A-2AF651762E8F

P698

Q35127445-D8214A63-D05E-44FC-82B8-86852DA54904

P921

Q35127445-32800442-6AA6-4AFE-9ECC-CCDD3E4501F4

P932

Q35127445-93931B56-EE9A-4842-A1D8-DC287361DFD4

P356

P1433

AIDS Patient Care and Stds

P1476

Effects of darunavir/ritonavir ...... n women and men over 48 weeks.

@en

P2093

Claudia Martorell

http://www.w3.org/2001/XMLSchema#string

Guy De La Rosa

http://www.w3.org/2001/XMLSchema#string

Joseph Mrus

http://www.w3.org/2001/XMLSchema#string

Judith S Currier

http://www.w3.org/2001/XMLSchema#string

Michael T Yin

http://www.w3.org/2001/XMLSchema#string

Olayemi Osiyemi

http://www.w3.org/2001/XMLSchema#string

Robert Ryan

http://www.w3.org/2001/XMLSchema#string

P2860

Self-perception of body fat changes and HAART adherence in the Women's Interagency HIV Study.

Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial.

The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men.

Gender-specific effects of HIV protease inhibitors on body mass in mice.

Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women.

Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns.

Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and women.

Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis.

The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition.

Effects of first-line use of nucleoside analogues, efavirenz, and ritonavir-boosted protease inhibitors on lipid levels.

P304

333-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/APC.2010.0386

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51165194

http://www.w3.org/2001/XMLSchema#string

P698

21612545

http://www.w3.org/2001/XMLSchema#string

P921

P932

3143406

http://www.w3.org/2001/XMLSchema#string